Peripheral/Endo

Surmodics Provides Update Regarding TRANSCEND Clinical Trial

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, has resumed patient enrollment into its TRANSCEND clinical trial and is nearly 75 percent of the way to its goal of 446 randomized patients. Patient enrollment in TRANSCEND, the […]

Surfacer® Inside-Out® Access Catheter System to be Featured at 2019 Charing Cross (CX) International Annual Symposium

SAN ANTONIO, April 15, 2019 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today events taking place at the Charing Cross (CX) International Symposium this week in London, United Kingdom on April 15-18, 2019. Leading clinicians will discuss experience with the Surfacer® Inside-Out® Access Catheter […]

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administration (FDA) approval for the Tack Endovascular System (6F), a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease (PAD). […]

DABRA Excimer Laser Atherectomy to be Presented in Key Events at Charing Cross International Symposium

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) today announced the schedule of key DABRA Excimer Laser Atherectomy events at the upcoming Charing Cross International Symposium in London April 16–18. These events include case and podium presentations and hands-on workshops with Charles Bailey, MD, interventional cardiologist at Heart Endovascular and Rhythm […]

Reflow Medical Announces Enrollment Completion in the Wing-IT IDE CTO Clinical Trial

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. has announced the completion of enrollment in its Wing-ITinvestigational device exemption trial, a prospective, multicenter, nonrandomized study evaluating the ability of the Wingman catheter to cross chronic total occlusions (CTOs) in peripheral lesions after failed guidewire attempts. Eighty-five patients with advanced peripheral artery disease enrolled in […]

Fist Assist Devices, LLC Announces Approval of FACT by University of Chicago Medical Center

LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device startup based in Silicon Valley, Calif., today announced the approval of FACT (Fist Assist Clinical Trial) by the University of Chicago Medical Center Institutional Review Board (IRB). This research will evaluate the effects of using the Fist Assist® device to […]

Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

CALGARY, Alberta, April 09, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment milestone in its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”). Enrollment rates have increased substantially over the past […]

FEops HEARTguide™ Receives CE Mark

GENT, Belgium–(BUSINESS WIRE)–FEops, a leader in personalized predictive planning for structural heart interventions, today announced that FEops HEARTguideTM has received CE mark approval. FEops HEARTguideTM is a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. The current release […]

SANUWAVE Receives U.S. and European Patents for Intracorporeal Shockwave Systems for Treating Blood Vessels in Cardiology and Endovascular Fields

SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, received United States Patent US 10,238,405 on March 26, 2019 entitled “Blood Vessel Treatment […]